Annette Marcantonio
Corporate Officer/Principal bei JASPER THERAPEUTICS, INC.
Aktive Positionen von Annette Marcantonio
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02.08.2023 | - |
Karriereverlauf von Annette Marcantonio
Ehemalige bekannte Positionen von Annette Marcantonio
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Corporate Officer/Principal | 01.09.2021 | 01.12.2022 |
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2016 | 01.10.2020 |
Ausbildung von Annette Marcantonio
Loyola Marymount University | Undergraduate Degree |
University of Phoenix | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JASPER THERAPEUTICS, INC. | Finance |
Private Unternehmen | 2 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
- Börse
- Insiders
- Annette Marcantonio
- Erfahrung